Brain Arteriovenous Malformation (AVM)

Causes, Symptoms, Diagnosis, Bleeding Risk, and Treatment Options

Most families only need the Quick Summary plus the sections on Bleeding Risk and Treatment Options. The rest is for deeper understanding.

What is a Brain AVM?

A brain arteriovenous malformation (AVM) is an abnormal connection between arteries and veins inside the brain.

Normally, blood flows:

artery → capillaries → vein

In an AVM, the capillary bed is missing.
Blood flows directly from high-pressure arteries into veins, forming a tangled cluster of vessels called a nidus. Veins are naturally designed for low-pressure blood; the high pressure from arteries causes them to stretch and weaken, similar to a balloon being overinflated.

Image: Arteriovenous malformation. The red part represents the arterial component, and the blue part represents the venous component of the malformation.

This causes:

• abnormally high pressure in veins,
• fragile vessel walls
• turbulent flow
• risk of rupture
• irritation of surrounding brain tissue

An AVM is therefore not a tumor — it is a high-flow vascular shunt (an abnormal „short circuit“ where blood flows directly from arteries into veins, bypassing the protective capillary bed) that carries a risk of rupture and disrupts normal blood flow within the brain.

Image: Frontal lobe brain AVM shown as a tangle of abnormal blood vessels (nidus). The red arrow indicates the feeding artery, while the blue arrow points to the draining vein of the malformation. An associated aneurysm on the feeding artery is marked with a green arrow. The yellow arrow indicates an intra-nidal aneurysm within the arterial part of the malformation.

Brain AVM Location

Brain arteriovenous malformations can occur anywhere in the brain, but their location significantly influences symptoms, hemorrhage risk, and treatment strategy.

Approximately 80–90% of AVMs are located in the supratentorial compartment, meaning within the cerebral hemispheres. These include:

• Cortical AVMs (involving the surface of the brain)
• Subcortical AVMs
• Deep AVMs affecting structures such as the basal ganglia or thalamus

The remaining 10–20% are infratentorial, involving the cerebellum or brainstem.

Location strongly affects clinical presentation:

• Cortical AVMs, particularly in the temporal and frontal lobes, are more commonly associated with epileptic seizures.
• Deep AVMs and those with exclusively deep venous drainage carry a higher risk of hemorrhage.
• Posterior fossa AVMs (cerebellum and brainstem) are less likely to present with seizures but may lead to more severe neurological deficits if bleeding occurs due to the limited space in this region.

Understanding the anatomical location of an AVM is essential for estimating individual risk and selecting the most appropriate management strategy.

Is Brain AVM Congenital?

Yes.
Brain AVMs are developmental (congenital) vascular malformations — they form during early fetal development, even though symptoms may not appear for decades.

They are not caused by lifestyle, blood pressure, or trauma.

How Common are AVMs?

Brain AVMs are rare:

• Estimated prevalence: ~10–20 per 100,000 people
• Many people never know they have one until imaging is done

Is Brain AVM Inherited?

Most AVMs are sporadic, meaning they occur by chance during development. They are not inherited, so you did not receive this from your parents, and you cannot pass it on to your children.

A slightly higher risk exists among first-degree relatives, but:

• the absolute risk remains low
• routine screening of family members is not recommended unless a known genetic syndrome is present (such as HHT — a condition causing abnormal blood vessel formation throughout the body).

When Do AVMs Become Symptomatic?

Although AVMs exist from birth, most become clinically evident between ages 15 and 45.

It is estimated that:

• Approximately 15–20% of AVMs remain „silent“ (asymptomatic) throughout a person’s life and are discovered only incidentally or during autopsy.
• Data across different series may vary, but approximately 80–85% of AVMs will eventually cause symptoms, with intracranial hemorrhage and seizures being the most common presentations.

They are discovered:

• After a hemorrhage (approx. 50% of cases): Often the first sign of an AVM’s presence.
• After seizures begin (approx. 20–30% of cases): Due to the impact of the malformation on the surrounding brain tissue.
• Incidentally on MRI (increasingly common): Found during scans for unrelated headaches or minor head injuries.

It is important to understand the fundamental differences between a brain AVM and a cerebral aneurysm, as they represent distinct vascular conditions with very different clinical behaviors. While both carry a risk of rupture, a ruptured aneurysm is statistically much more lethal, with mortality rates reaching 40–50% due to high-pressure bleeding into the subarachnoid space. In contrast, an AVM rupture has a significantly lower mortality rate of approximately 10–15%, as the bleeding is typically contained within the brain tissue (intracerebral) and often occurs at lower pressures. In AVM, outcomes after a bleed vary widely depending on the location, volume, and initial clinical grade of the hemorrhage. Furthermore, while an aneurysm is generally a single weak point or „blister“ on an artery, an AVM is a complex network that can also cause seizures or progressive neurological deficits by disrupting normal circulation over many years, even without bleeding.

What Are the Symptoms of an AVM if It Has Not Bled?

An AVM can cause neurological problems even if it has never ruptured.

1) Epileptic Seizures

Seizures are the second most common symptom of a brain AVM, occurring in approximately 20–30% of cases. They often serve as the first warning sign that leads to diagnosis.

Population-based studies suggest that the 5-year risk of experiencing a first seizure in patients with an untreated AVM is approximately 8%, and higher (up to ~20%) in those who have already suffered a hemorrhage.

If a first seizure occurs, the probability of developing epilepsy (recurrent unprovoked seizures) within the following five years is approximately 50–60%.

Seizures are significantly more common in AVMs involving the cerebral cortex, particularly in the temporal and frontal lobes. Deep-seated or cerebellar AVMs are much less likely to present with seizures and more often manifest with hemorrhage.

The „short circuit“ of the AVM causes chronic irritation to the surrounding brain cortex through several mechanisms:

• Steal phenomenon: Abnormal blood flow „steals“ oxygen from healthy tissue.
• Microscopic bleeding & Iron deposition: Small, undetected leaks leave iron deposits (hemosiderin) that are highly irritating to neurons.
• Gliosis: The formation of scar tissue around the malformation.

Some patients may experience seizures for years before the AVM is finally discovered on an MRI scan.

2) Chronic Headache Or Migraine-like Pain

Chronic or migraine-like headaches occur in up to 15–40% of patients with an AVM. While common, they are considered „non-specific“ because they can mimic standard migraines.

The pain is typically not caused by the AVM tissue itself, but by:

• Venous Congestion: The high-pressure flow causes „overcrowding“ in the veins, increasing local pressure.
• Vascular Stretching: The abnormal vessels stretch the pain-sensitive linings of the brain (dura mater).
• Meningeal Irritation: Minor, asymptomatic „micro-bleeds“ can irritate the brain’s surface.

For many patients, any persistent or recurring headache naturally causes anxiety that the AVM is the cause. While localized pain on the same side as the AVM is clinically significant, it is important to remember that AVM patients can also suffer from common, unrelated tension headaches or migraines. Distinguishing whether a headache is a direct symptom of the vascular shunt or an independent condition is a key part of the neurological evaluation.

3) Neurological Deficits

Less commonly, AVMs cause:

• weakness
• numbness
• vision problems
• speech problems

Mechanisms include:

• chronic venous hypertension
• “steal phenomenon” (blood diverted away from the normal brain), causing micro-ischemia in brain tissue around AVM

4) Cranial Nerve Compression (rare)

In unusual anatomical locations, enlarged draining veins may compress cranial nerves (for example causing trigeminal neuralgia or visual disturbances), but this is uncommon.

What Happens When an AVM Bleeds?

AVM rupture causes intracranial hemorrhage.

Most commonly:

• intracerebral hemorrhage (ICH): Bleeding directly into the brain tissue itself (the most common type for AVMs).
  Sometimes:
• Subarachnoid hemorrhage (SAH): Bleeding into the fluid-filled space surrounding the brain.
• Intraventricular hemorrhage (IVH): Bleeding into the brain’s ventricles (the internal chambers where spinal fluid is produced).
• Combinations of these: In extensive ruptures, blood may spread across multiple compartments.

Symptoms may include:

• sudden severe headache
• vomiting
• weakness or paralysis
• speech or vision loss
• loss of consciousness or coma
• seizures

Unlike aneurysm rupture, AVM hemorrhage:

• does not cause classic vasospasm
• has a different rebleeding pattern
• is dominated by the mass effect of the clot and brain injury

What Is the Risk That an AVM Will Bleed?

The risk depends on anatomy and prior rupture.

If the AVM Has Never Bled

Annual hemorrhage risk:
~1–3% per year

If the AVM Has Already Bled

Annual hemorrhage risk increases to:
~4–6% per year

Factors that increase bleeding risk:

• prior hemorrhage
• deep venous drainage
• deep brain location
• associated aneurysms on feeding arteries
• high-flow shunts

How Brain AVMs are Classified and How It Guides Treatment (Spetzler–Martin System)

This system scores three features:

Total = Grade I to V

The Spetzler–Martin grading system estimates the surgical risk of AVM resection based on nidus size, eloquence of adjacent brain, and venous drainage pattern. While it was developed to predict microsurgical risk, it also indirectly guides overall treatment strategy. Prior hemorrhage significantly influences decision-making but does not override anatomical risk.

Unruptured: Generally favorable for microsurgical resection, with high cure rates and low permanent morbidity in experienced centers. However, anatomical suitability alone does not mandate surgery. The decision also depends on patient age, symptom profile (for example, drug-resistant epilepsy or progressive neurological deficit), estimated lifetime hemorrhage risk, and individual comorbidities. In younger patients with long life expectancy, definitive elimination of hemorrhage risk is often considered reasonable. In older asymptomatic patients, careful observation may be equally appropriate.

Radiosurgery or selective endovascular strategies may be appropriate in certain patients, particularly when the lesion is located in eloquent or deep regions, when surgical risk is increased due to comorbidities, or when the patient prefers a less invasive approach.

Ruptured: Definitive surgical removal is usually strongly considered after stabilization, as it eliminates the risk of recurrent hemorrhage. Alternative or adjunctive treatments (such as embolization of associated aneurysms or radiosurgery in selected cases) may be incorporated depending on angioarchitecture and overall risk profile.

Grade III

Unruptured: Heterogeneous group. Some lesions are appropriate for surgery, others for radiosurgery or staged multimodal treatment. Individual anatomical features and center expertise are critical.

Ruptured: Hemorrhage increases the likelihood of active treatment, but management remains individualized.

Grade IV–V

Unruptured: Very high treatment risk. Large or deep-seated AVMs in this category are often not suitable for single-step complete removal. In many cases, management focuses on risk reduction rather than cure. Options may include staged embolization, targeted treatment of high-risk components, limited or staged radiosurgery in selected anatomy, or careful observation with symptom control.

Ruptured: Even after hemorrhage, complete resection remains high risk. Management may prioritize life-saving measures and selective stabilization rather than aggressive curative intent.

Important: In large high-grade AVMs, the natural history risk may be lower than the procedural risk. Hemorrhage increases urgency, but it does not automatically convert a high-grade AVM into a safe surgical candidate. Final decisions must balance natural history risk, patient age, neurological status, and center-specific expertise.

How AVMs are Diagnosed

CT Scan

Used in emergencies to detect bleeding.

CTA (CT Angiography)

Shows large vessels and may reveal the AVM.

MRI / MRA

Provides:

• brain damage from prior bleeds
• microhemorrhages
• seizure-related scarring
• AVM location and size

Digital Subtraction Angiography (DSA)

This is the gold standard. DSA is a minimally invasive imaging technique performed under local anesthesia, often with light conscious sedation to ensure the patient is comfortable and relaxed.

A neuro-radiologist inserts a thin catheter, typically through a puncture in the femoral artery (in the groin) or the radial artery (in the wrist). The catheter is then carefully navigated through the major blood vessels up to the arteries supplying the brain. Once positioned, a contrast agent is injected. This substance allows high-resolution, real-time X-ray images to visualize the blood flow, which clearly outlines the arteries and identifies AVMs, aneurysms, or other vascular pathologies.

It shows:

• feeding arteries
• nidus
• draining veins
• flow patterns
• associated aneurysms

If hemorrhage occurred, DSA helps determine:

• whether the AVM itself ruptured
• or whether an associated aneurysm was the bleeding source

This distinction is crucial for treatment planning.

Image: The red arrow on the left shows a brain AVM on an MRI scan. The red arrow on the right shows the same AVM case on a DSA.

How Brain AVMs are Treated

The treatment of a brain AVM primarily depends on whether it has bled or not.

Treatment If the Brain AVM Has Bled

Management involves treating the hemorrhage first, followed by the treatment of the AVM itself.

1. Emergency care of hemorrhage
If there is a large clot compressing the brain, it may need urgent surgical removal. Management of an AVM-induced intracerebral hemorrhage (ICH) follows the same emergency principles as other hemorrhagic strokes.

Key differences in AVM bleeding:
• Aneurysm priority: If a brain AVM is associated with an aneurysm, the first priority is to treat the lesion that actually caused the bleeding — especially if the hemorrhage came from the aneurysm. In selected cases, both the aneurysm and the AVM can be treated during the same procedure.
• Higher need for surgery: AVM hemorrhages are often more superficial or atypically located compared to hypertensive bleeds. Consequently, they more frequently require surgical evacuation to relieve pressure from a significant clot.

2. AVM strategy when bled

After stabilization, the team decides on the best path forward:

• Can the AVM be safely removed during the same procedure as the clot evacuation, or should it be delayed?
• Should it be embolized first?
• Should radiosurgery be used later?

This is often multimodal treatment.

Treatment If the Brain AVM Has Not Bled

Step 1 – Treat symptoms

• Seizures → antiseizure medications
• Headache → evaluate for migraine, cervical, sinus, medication-overuse, and other types of headache.

Step 2 – Decide on AVM elimination: either removing the nidus or permanently stopping the blood flow through it.

Not every AVM should be treated.

The ARUBA trial showed that, in the short term, conservative management of unruptured AVMs was safer than intervention. However, this remains controversial, and modern specialized centers use careful patient selection. The decision is always individualized; for instance, a young patient with a 50-year life expectancy faces a vastly different cumulative risk of hemorrhage than an older patient.

The primary methods to eliminate blood flow through an AVM include: surgical resection, stereotactic radiosurgery, endovascular embolization, or a combined multimodality treatment approach. Partial treatment does not solve a problem — residual AVM continues to carry the same bleeding risk, so the goal is complete obliteration when treatment is chosen.

The decision on whether to treat an AVM and which modality to use depends on:

• SM (Spetzler–Martin system) grade- size, location and type of venous drainage
• bleeding risk
• patient age
• expected lifetime risk
• treatment risks

Surgical Removal of AVM (Microsurgery)

Surgery is performed only when complete removal can be achieved safely.

During surgery:

• craniotomy is performed to approach AVM
• the surgery is performed under microsurgical magnification
• feeding arteries of AVM are identified and closed first
• the AVM gradually collapses and it is carefully separated from the brain.
• draining veins of AVM are preserved until the very end
• only after all arteries are disconnected is the main vein coagulated and cut
• the nidus is removed

Cutting the vein too early would cause catastrophic bleeding.

Intraoperative angiography may be used to confirm complete removal.

Read more about potential complications following craniotomy and open brain surgery on this page.

Image: Surgical resection of a brain AVM. During the procedure, the feeding arteries of the AVM are identified and closed first, causing the malformation to gradually collapse. The draining veins are strictly preserved until the very end. Only after all arterial feeders have been disconnected is the main vein cut, allowing for the safe removal of the nidus.

Stereotactic Radiosurgery (Gamma Knife, CyberKnife, LINAC)

Used mainly for:

• small AVMs (usually ≤3 cm)
• deep or eloquent locations (areas of the brain controlling speech, movement, or vision)
• residual AVM after embolization or surgery

How it works: High-dose radiation targets the nidus, causing progressive damage to the vessel lining. Over time, this leads to progressive scarring and eventual closure (obliteration) of the malformation.

Dosing and Sessions:

• Dose: Typically, a single high dose of 15 to 25 Gy (Grays) is delivered precisely to the nidus.
• Sessions: Usually performed as a single-session treatment. However, for slightly larger or complex AVMs, staged-volume radiosurgery (dividing the AVM into parts treated months apart) or fractionated sessions may be used to protect the surrounding healthy brain tissue.

The “Waiting Period”
The closure is not immediate; it typically takes 2–3 years for the AVM to fully disappear. During that time:
• The AVM is still present: The malformation does not vanish immediately and remains part of the brain’s circulation.
• The risk of bleeding continues: The risk of rupture remains at its baseline rate until the closure is complete.
• Regular follow-up is required: Periodic MRI/MRA scans are necessary to monitor the progress, with a final digital subtraction angiography (DSA) to confirm total obliteration.

Repeat Radiosurgery

If complete obliteration is not achieved after the initial radiosurgical treatment (typically assessed 2–3 years later with MRI and confirmatory DSA), repeat radiosurgery may be considered in selected patients. This approach is most appropriate for small residual nidus volumes. The decision depends on residual size, location, prior radiation dose, patient age, and cumulative risk of radiation-induced injury. While repeat treatment can increase overall obliteration rates, it must be carefully balanced against the risk of delayed radiation-related complications.

Endovascular embolization (gluing)

During endovascular embolization, a microcatheter is advanced through a feeding artery (the standard transarterial approach) as close as possible to the AVM nidus. The catheter insertion technique is the same as that used for DSA. A liquid embolic agent (such as Onyx or n-BCA “medical glue”) is then injected with the aim of penetrating and filling the nidus itself, so that the abnormal arteriovenous shunt is closed from within. The goal is not simply to occlude proximal feeding arteries, because isolated feeder occlusion may recruit collateral supply and usually does not cure the AVM. While selective feeder embolization may be used as part of surgical preparation, targeted rupture control, or palliative flow reduction, only nidus-directed embolization is considered curative for brain AVMs.

In selected cases, embolization is performed as part of a multimodality plan or as a primary intervention:

• (1) Pre-operative embolization: Performed to reduce intraoperative bleeding and surgical complexity by occluding deep or difficult-to-reach feeders.
• (2) Pre-radiosurgery embolization: Used to reduce the nidus size or treat high-risk compartments, making the malformation more suitable for targeted radiation.
• (3) Targeted or palliative embolization: Aimed at securing a focal “weak point” (such as an intranidal aneurysm or a ruptured compartment) when immediate complete cure is not feasible.
• (4) Stand-alone treatment: Employed in selected small AVMs where complete obliteration is achievable through filling of the nidus alone.

It is rarely curative alone for complex AVMs. Complete cure requires elimination of the nidus, not just proximal flow reduction.

Risks include:

• stroke
• hemorrhage
• vessel perforation
• venous thrombosis

These risks are minimized through careful patient selection, high-resolution angiography, and experienced neurointerventional teams.

Transvenous approach (special technique)

The transvenous approach (embolization through the draining vein rather than the feeding arteries) is an emerging technique used only in highly selected AVMs, typically those with:
• small, compact nidus
• single or favorable venous drainage
• anatomy suitable for controlled retrograde filling

Special anti-reflux strategies (such as “pressure-cooker” techniques) are used to allow safe retrograde penetration of the nidus while protecting the normal veins. This approach is not standard embolization and is reserved for centers with advanced expertise.

Image: Endovascular embolization techniques. The left side shows the common transarterial approach, while the right side shows the transvenous approach.

Image: Endovascular embolization of an AVM. A microcatheter delivers a liquid embolic agent („medical glue“) directly into the nidus to close the abnormal shunt from within.

In Conclusion: When Is „No Treatment“ the Best Option?

Some AVMs are best left untreated and monitored through regular imaging. This is typically the case for:

• Spetzler-Martin Grade IV & V: Large malformations (often > 6 cm) where the risk of surgery outweighs the risk of natural history.
• Deep-seated or eloquent locations: When the AVM is in a region where any intervention could cause a major neurological deficit.
• Asymptomatic lesions: AVMs that have never bled, especially in older patients where the cumulative lifetime risk of hemorrhage is lower than the risk of intervention.

Why Do Medical Opinions Differ in Brain AVM Treatment?

Differences in medical opinion are common because treatment decisions depend on how bleeding risk, AVM anatomy, patient age, and treatment risk are balanced against each other, rather than on a single finding.

Is The AVM Dangerous Enough To Require Treatment?

Some specialists recommend treatment based on the presence of an AVM alone, while others consider intervention only if there is significant lifetime hemorrhage risk, especially in younger patients or after prior bleeding.

Should An Unruptured AVM Be Treated Or Observed?

Some follow the ARUBA-based conservative approach, recommending observation for unruptured AVMs, while others advocate treatment in selected patients with favorable anatomy and long life expectancy, where cumulative bleeding risk becomes relevant.

Which Treatment Option Is The Safest And Most Effective?

There is no single best method, as some recommend microsurgery for low-grade AVMs, others favor radiosurgery for deep or eloquent locations, while embolization is often used as part of a combined strategy rather than a standalone cure.

Can Partial Treatment Reduce Risk Or Is Complete Obliteration Necessary?

Some believe that reducing flow or treating high-risk components is sufficient, while most specialists emphasize that only complete elimination of the nidus removes the bleeding risk, and partial treatment may leave the patient exposed.

When Is “No Treatment” Actually The Best Option?

In large, deep, or high-grade AVMs, different specialists and centers may assess treatment risk differently based on their experience and expertise. Some consider intervention justified when they believe the risk can be controlled, while others recommend observation when the estimated procedural risk exceeds the natural history risk of the AVM.

AVM and Epilepsy

In patients with unruptured brain AVMs, seizures are the presenting symptom in approximately 25–40% of cases, making AVMs a leading cause of secondary (structural) epilepsy in young adults.

Treatment Strategy for AVM-Related Epilepsy:

• Medication First: Initially, seizures are managed with anti-seizure medications.
• When to Consider Intervention:
  • Refractory Epilepsy: If seizures cannot be controlled with medication, AVM elimination (resection, radiosurgery) or specialized epilepsy surgery may be considered to reduce seizure frequency.
  • Preventive Elimination (Grade I–II): In younger patients with favorable anatomy (Spetzler–Martin Grade I or II), complete AVM removal is often recommended even if seizures are well-controlled. This is done to eliminate the cumulative, lifelong risk of hemorrhage and to potentially cure the epilepsy by removing the structural cause.

Clinical Take-Home Message

A brain AVM is a congenital vascular short-circuit that can cause:

• bleeding
• seizures
• neurological deficits

Some AVMs must be treated urgently.
Others should never be touched.

Correct management requires:

• precise angiographic analysis
• understanding of natural history
• and realistic weighing of risk vs benefit.

This is exactly where expert second-opinion consultation makes the biggest difference.

Frequently Asked Questions About Brain AVM (Arteriovenous Malformations)

On this page, you can learn more about other neurosurgical cerebrovascular diseases, such as aneurysms, cavernomas, and intracerebral hemorrhages.